Your browser doesn't support javascript.
loading
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.
Barbati, Melissa; Kicinski, Michal; Suciu, Stefan; Mazingue, Françoise; Vandecruys, Els; Plat, Geneviève; Uyttebroeck, Anne; Paillard, Catherine; Dresse, Marie-Françoise; Simon, Pauline; Pluchart, Claire; Minckes, Odile; Ferster, Alina; Freycon, Claire; Millot, Frederic; Van Der Werff Ten Bosch, Jutte; Chantrain, Christophe; Paulus, Robert; de Schaetzen, Gaetan; Rossi, Giovanna; Rohrlich, Pierre; Benoit, Yves; Piette, Caroline.
Afiliação
  • Barbati M; Department of Pediatric Hematology-Oncology, CHRU Lille, Lille, France.
  • Kicinski M; Statistics Department, EORTC Headquarters, Brussels, Belgium.
  • Suciu S; Statistics Department, EORTC Headquarters, Brussels, Belgium.
  • Mazingue F; Department of Pediatric Hematology-Oncology, CHRU Lille, Lille, France.
  • Vandecruys E; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
  • Plat G; Department of Hematology, CHU Toulouse, Toulouse, France.
  • Uyttebroeck A; Department of Pediatric Hemato-Oncology, University Hospital Leuven, Leuven, Belgium.
  • Paillard C; Department of Pediatric Hematology-Oncology, CHRU Strasbourg, Strasbourg, France.
  • Dresse MF; Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
  • Simon P; Pediatric Oncology, CHRU Besançon, Besançon, France.
  • Pluchart C; Department of Pediatric Haematology and Oncology, CHU Reims, Reims, France.
  • Minckes O; Department of Pediatric Hematology-Oncology, CHU Caen, Caen, France.
  • Ferster A; Department of Hemato-Oncology, HUDERF (ULB), Brussels, Belgium.
  • Freycon C; Department of Pediatric Hematology-Oncology, CHU Grenoble, Grenoble, France.
  • Millot F; Department of Pediatric Hematology-Oncology, CHU Poitiers, Poitiers, France.
  • Van Der Werff Ten Bosch J; VUB, Brussels, Belgium.
  • Chantrain C; CHC Mont Legia, Liège, Belgium.
  • Paulus R; CHR Verviers East Belgium, Verviers, Belgium.
  • de Schaetzen G; EORTC Headquarters, Brussels, Belgium.
  • Rossi G; Medical Department, EORTC Headquarters, Brussels, Belgium.
  • Rohrlich P; Pediatric Oncology, CHU Nice, Nice, France.
  • Benoit Y; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
  • Piette C; Department of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
Eur J Cancer Care (Engl) ; 31(6): e13755, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36284405
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude Limite: Adult / Humans Idioma: En Revista: Eur J Cancer Care (Engl) Assunto da revista: ENFERMAGEM / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude Limite: Adult / Humans Idioma: En Revista: Eur J Cancer Care (Engl) Assunto da revista: ENFERMAGEM / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido